A LinkedIn post from Single Quantum describes the company’s presence at the Focus on Microscopy 2026 conference, where it is demonstrating high‑sensitivity imaging capabilities. The post highlights an integrated setup combining a PicoQuant confocal microscope with Single Quantum’s R12 superconducting nanowire single-photon detector (SNSPD) system aimed at pushing visible, near‑infrared, and short‑wave infrared fluorescence imaging performance.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to the post, the showcased system emphasizes high detection efficiency across VIS, NIR, and SWIR bands, ultra‑low dark counts for improved signal‑to‑noise, and sub‑15 picosecond timing resolution for time‑resolved microscopy techniques such as FLIM and TRPL. It also points to deep‑tissue imaging capabilities at optical windows around 1000 nm, 1400 nm, and 1900 nm, suggesting potential relevance for advanced biological and medical imaging applications.
From an investor perspective, the post suggests that Single Quantum is positioning its SNSPD technology as a high‑end solution for research‑grade microscopy and time‑resolved imaging, potentially broadening its addressable market beyond quantum communications and fundamental physics experiments. Demonstrating an integrated solution with a recognized microscopy partner like PicoQuant may help validate the technology for lab adoption, support future commercial partnerships, and enhance the company’s competitive standing in specialized imaging and photonics markets.
While the post is promotional in tone and does not provide financial metrics, it indicates ongoing product development and application‑specific engineering that could translate into higher‑value system sales or integration contracts over time. If this integration approach gains traction among researchers and imaging specialists, it could support a premium pricing strategy and recurring demand from life sciences and materials science customers, which may be relevant for assessing Single Quantum’s long‑term revenue growth potential.

